Yüklüyor......

Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma

Despite the relatively high long-term disease-free survival (DFS) rate for patients with Hodgkin lymphoma (HL) with modern combination chemotherapy or combined modality regimens, ∼20% of patients die from progressive or relapsed disease. The standard treatment for relapsed and primary refractory HL...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Colpo, Anna, Hochberg, Ephraim, Chen, Yi-Bin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3267827/
https://ncbi.nlm.nih.gov/pubmed/22210089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0177
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!